RESUMO
Radiotherapy (RT) is part of the standard treatment of breast cancer (BC) because of its effects on relapse reduction and survival. However, response to treatment is highly variable, and some patients may develop disease progression (DP), a second primary cancer, or may succumb to the disease. Antioxidant systems and inflammatory processes are associated with the onset and development of BC and play a role in resistance to treatment. Here, we report our investigation into the clinical evolution of BC patients, and the impact of RT on the circulating levels of the antioxidant enzyme paraoxonase-1 (PON1), cytokines, and other standard biochemical and hematological variables. Gradient Boosting Machine (GBM) algorithm was used to identify predictive variables. This was a retrospective study in 237 patients with BC. Blood samples were obtained pre- and post-RT, with samples of healthy women used as control subjects. Results showed that 24 patients had DP eight years post-RT, and eight patients developed a second primary tumor. The algorithm identified interleukin-4 and total lymphocyte counts as the most relevant indices discriminating between BC patients and control subjects, while neutrophils, total leukocytes, eosinophils, very low-density lipoprotein cholesterol, and PON1 activity were potential predictors of fatal outcome.
RESUMO
BACKGROUND: Diet can help preserve lung function in smokers, as well as aid individuals who avoid smoking. This study aimed to evaluate the effectiveness of a nutritional intervention, using the Social Networks 2.0 tool, to increase adherence to the Mediterranean diet (MD) and improve lung function in smokers without prior respiratory disease. METHODS: A randomized controlled parallel design was used. The participants were assigned to either the intervention or control group. Data from representative smokers without respiratory disease (n = 77) aged 18-70 years were analyzed. The participants completed a validated semi-quantitative food-frequency questionnaire, and their adherence to the diet was evaluated by using the questionnaire called the Mediterranean Diet Adherence Score (MEDAS, with 14 items), which considers ≥9 points to indicate high adherence. The lung function was assessed by spirometry. Associations among variables were determined by logistic regression. RESULTS: A comparison of the variables at the end of the study between the control and intervention groups showed that the intervention significantly increased adherence to the MD based on the MEDAS questionnaire (0.69 (2.1) vs. 2.05 (2.03); p = 0.009). Specifically, the consumption of fruits was increased after two years in both groups; however, a more significant increase was detected in the intervention group (121 (178) vs. 12.7 (167) in the control group; p-value = 0.008). In the unadjusted analysis, the intervention only showed a statistical significant increase in the score of adherence to the MD (ß: 1.36; 95% CI 0.35; 2.3; p = 0.009), and this increase was maintained after adjusting for age and sex (ß: 1.15; 95% CI 0.05; 2.2; p = 0.040) and after adjusting for various sociodemographic, lifestyle and anthropometric variables (ß: 1.17; 95% CI 0.02; 2.31; p = 0.046). The pulmonary function parameters improved more in the intervention group; however, no significant differences were observed between the two groups. CONCLUSIONS: A nutritional intervention based on a dietetic-nutritional education program resulted in a significant increase in adherence to the MD. However, some evidence suggests that an MD dietary intervention can improve lung function, but in our study, we were not able to demonstrate this. Further research is needed to obtain more robust data and confirm a possible benefit of the program before it can be extended to general practice.
Assuntos
Dieta Mediterrânea , Pulmão/fisiopatologia , Motivação , Cooperação do Paciente , Testes de Função Respiratória , Fumantes , Rede Social , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-IdadeRESUMO
Data on the association between lung function and some dietary patterns have been published. However, it is not yet well known if whether the Mediterranean Diet (MD) pattern can preserve or improve lung function. Our purpose is to evaluate the effect of increased MD adherence on lung function in smokers. A multicenter, parallel, cluster-randomized, controlled clinical trial is proposed. A total of 566 active smokers (>10 packs-year), aged 25-75 years will be included, without previous respiratory disease and who sign an informed consent to participate. Twenty Primary Care Centres in Tarragona (Spain) will be randomly assigned to a control or an intervention group (1:1). All participants will receive advice to quit smoking, and the intervention group, a nutritional intervention (2 years) designed to increase MD adherence by: (1) annual visit to deliver personalized nutritional education, (2) annual telephone contact to reinforce the intervention, and (3) access to an online dietary blog. We will evaluate (annually for 2 years): pulmonary function by forced spirometry and MD adherence by a 14-item questionnaire and medical tests (oxidation, inflammation and consumption biomarkers). In a statistical analysis by intention-to-treat basis, with the individual smoker as unit of analysis, pulmonary function and MD adherence in both groups will be compared; logistic regression models will be applied to analyze their associations. We hope to observe an increased MD adherence that may prevent the deterioration of lung function in smokers without previous respiratory disease. This population may benefit from a dietary intervention, together with the recommendation of smoking cessation.
Assuntos
Dieta Mediterrânea , Pulmão/fisiopatologia , Atenção Primária à Saúde/métodos , Doença Pulmonar Obstrutiva Crônica/dietoterapia , Abandono do Hábito de Fumar/métodos , Fumar/terapia , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto , EspirometriaRESUMO
El estilo de vida es un concepto complejo que incluye los aspectos externos a nosotros mismos que pueden modular e influir en nuestra salud. Los conocimientos sobre la relación entre el estilo de vida y el riesgo cardiovascular están lejos de proporcionar los niveles de evidencia que se han conseguido con los ensayos clínicos con fármacos, debido a que los estudios son escasos, fundamentalmente de tipo observacional y en grandes cohortes, con la dificultad añadida de la no existencia de métodos seguros para conocer con precisión la ingesta diaria o lo largo de tiempo, así como la dificultad en la recogida de datos y en la medición de la adherencia debido a diferencias en la composición de los alimentos en distintas épocas y a la conducta alimentaria cambiante que posee el ser humano a lo largo del tiempo. En este documento nos hemos propuesto llevar a cabo una revisión actualizada y jerarquizada en base a las evidencias actuales, prestando atención a tres aspectos que tienen gran importancia patogénica y que podemos modificar directamente: la actividad física, el consumo de tabaco y el patrón de alimentación. Con ello pretendemos actualizar los nuevos conocimientos sobre su relación con el riesgo cardiovascular aportando evidencias útiles, constituyendo una herramienta sencilla dirigida especialmente a todos los profesionales de la salud implicados en el cuidado de personas con riesgo cardiovascular para trasladarlos a la práctica clínica, definiendo unas líneas de actuación sencillas y fáciles para ser transmitidas a las personas que reciban un consejo para la prevención primaria y secundaria de las enfermedades cardiovasculares
Lifestyle is a complex concept that includes aspects external to ourselves that can modulate and influence our health. The knowledge of the relationship between lifestyle and cardiovascular risk does not attain the level of evidence achieved with clinical trials with drugs, because clinical studies are scarce and mainly of observational nature, albeit based on large cohorts. Nutritional epidemiology has the added difficulty of being based mostly on subjective dietary recall methods to ascertain nutrient and food intake over time, with the additional problems of incomplete data collection, variable measurements of adherence due to seasonal and geographical differences in food composition, and the changing eating behavior that human beings have over time. The purpose of this document is to carry out an updated and hierarchical review of the relationship between lifestyle and cardiovascular disease based on current evidence, paying attention to three aspects that are of great pathogenic importance and are directly modifiable: physical activity, tobacco consumption, and diet. With this, we intend to update the knowledge on this relationship, construct evidence-based recommendations, and provide a simple tool for clinical practice especially directed to health professionals involved in the care of people at cardiovascular risk, defining simple and easy strategies for individuals who receive advice for the primary and secondary prevention of cardiovascular diseases
Assuntos
Humanos , Doenças Cardiovasculares/prevenção & controle , Estilo de Vida , 24457 , Dieta Mediterrânea , Exercício Físico/fisiologia , Tabagismo/complicações , Consumo de Bebidas Alcoólicas/efeitos adversos , Alimento Funcional , Fatores de RiscoRESUMO
Lifestyle is a complex concept that includes aspects external to ourselves that can modulate and influence our health. The knowledge of the relationship between lifestyle and cardiovascular risk does not attain the level of evidence achieved with clinical trials with drugs, because clinical studies are scarce and mainly of observational nature, albeit based on large cohorts. Nutritional epidemiology has the added difficulty of being based mostly on subjective dietary recall methods to ascertain nutrient and food intake over time, with the additional problems of incomplete data collection, variable measurements of adherence due to seasonal and geographical differences in food composition, and the changing eating behavior that human beings have over time. The purpose of this document is to carry out an updated and hierarchical review of the relationship between lifestyle and cardiovascular disease based on current evidence, paying attention to three aspects that are of great pathogenic importance and are directly modifiable: physical activity, tobacco consumption, and diet. With this, we intend to update the knowledge on this relationship, construct evidence-based recommendations, and provide a simple tool for clinical practice especially directed to health professionals involved in the care of people at cardiovascular risk, defining simple and easy strategies for individuals who receive advice for the primary and secondary prevention of cardiovascular diseases.
Assuntos
Doenças Cardiovasculares/prevenção & controle , Comportamentos Relacionados com a Saúde , Estilo de Vida , Doenças Cardiovasculares/etiologia , Dieta , Exercício Físico/fisiologia , Humanos , Fatores de Risco , Uso de Tabaco/efeitos adversosRESUMO
OBJECTIVE: In order to clarify the relation between deprivation and morbillity and mortality, in function of different residence places, we design this study. Main objective is to analyze the influence of place of residence on the incidence of cardiovascular events (CVD) and general mortality from any cause, in a cohort with metabolic syndrome. METHODS: Prospective study to determine the incidence of CVD according to the place of residence (rural, urban) in individuals with different combinations of clinical features of Metabolic Syndrome (MS). Setting: Primary Care, Catalonia (Spain). Subjects: between 35-75 years of age fulfilling SM criteria, without CVD at the beginning of follow-up (2009). The population was stratified according to the MEDEA index in rural, and within urban areas in 5 subcategories (urban1 - urban5), according to their level of deprivation. We performed descriptive statistics, variance analysis and survival curves (Kaplan-Meier and Cox methods) in order to contrast data from different categories. RESULTS: We analyzed 401,743 subjects with MS (17.2% of the Catalan population); 20.1% resided in rural areas. Their average age ranged between 60.5 + 9.6 years in urban area 1 (most favored) and 59.6 + 10.4 years in urban area 5 (the most precarious). After 5 years of follow-up, the global incidence of CVD was 5.5%, being slightly lower in rural areas (5%) than in urban areas (between 5.5% -5.8%). On the other hand, mortality was higher in the rural area (859 deaths/100000 inhabitants-year) - than in the rest of the areas (minimum value in urban-3 (736 deaths/100000 inhabitants-year)). CONCLUSIONS: The place of residence is a risk marker, which is associated with the incidence of CVD but above all, with higher mortality from all causes in patients with MS. Undoubtedly and leaving aside the possible confounding factors, in the socioeconomically most disadvantaged areas, mortality is increased.
OBJETIVO: Con el fin de evidenciar la posible relación entre deprivación y morbimortalidad, enmarcada en diferentes lugares de residencia, diseñamos el presente estudio. El objetivo de este trabajo fue analizar la influencia del lugar de residencia sobre la incidencia de eventos cardiovasculares (ECV) y de mortalidad general por cualquier causa, en una cohorte con síndrome metabólico. METODOS: Estudio prospectivo para determinar la incidencia de ECV según el lugar de residencia (rural, urbano) en individuos con distintas combinaciones de rasgos clínicos de Síndrome Metabólico (SM). El emplazamiento del mismo fue la Atención Primaria de Cataluña (España). Los sujetos de estudio fueron personas de entre 35-75 años de edad, que cumplían los criterios de SM, sin ECV al inicio del seguimiento (2009). La población se estratificó según el índice MEDEA en rural, y dentro de áreas urbanas en 5 subcategorías (urbano1 urbano5), según su nivel de deprivación. Se realizó estadística descriptiva, análisis de la varianza y curvas de supervivencia (Kaplan-Meier, método de Cox) para contrastar los diferentes grupos categóricos. RESULTADOS: Se analizaron 401.743 sujetos con SM (17,2% de la población catalana); 20,1% residían en áreas rurales. Su edad media osciló entre 60,5 + 9,6 años en área urbana 1 (la más favorecida) y 59,6 + 10,4 años en área urbana 5 (la más precaria). A los 5 años de seguimiento, la incidencia global de ECV fue del 5,5%, siendo ligeramente menor en ámbito rural (5%) que en los urbanos (entre 5,5-5,8%). En cambio, la mortalidad fue superior en el ámbito rural (859 casos/100000 habitantes-año) - que en el resto de áreas (mínimo valor en urbano-3 (736 casos/100000 habitantes-año)). CONCLUSIONES: El lugar de residencia constituye un marcador de riesgo, que se asocia a la incidencia de ECV pero sobre todo, a una mayor mortalidad por todas las causas, en pacientes con SM. Sin duda y dejando de lado los posibles factores de confusión, en las áreas socioeconómicamente más desfavorecidas, la mortalidad está aumentada.
Assuntos
Doenças Cardiovasculares/complicações , Doenças Cardiovasculares/mortalidade , Síndrome Metabólica/complicações , Síndrome Metabólica/mortalidade , Características de Residência , Adulto , Idoso , Doenças Cardiovasculares/epidemiologia , Feminino , Humanos , Incidência , Estimativa de Kaplan-Meier , Masculino , Síndrome Metabólica/epidemiologia , Pessoa de Meia-Idade , Modelos de Riscos Proporcionais , Estudos Prospectivos , Fatores de Risco , População Rural , Espanha/epidemiologia , População Urbana , Adulto JovemRESUMO
Fundamentos: Con el fin de evidenciar la posible relación entre deprivación y morbimortalidad, enmarcada en diferentes lugares de residencia, diseñamos el presente estudio. El objetivo de este trabajo fue analizar la influencia del lugar de residencia sobre la incidencia de eventos cardiovasculares (ECV) y de mortalidad general por cualquier causa, en una cohorte con síndrome metabólico. Métodos: Estudio prospectivo para determinar la incidencia de ECV según el lugar de residencia (rural, urbano) en individuos con distintas combinaciones de rasgos clínicos de Síndrome Metabólico (SM). El emplazamiento del mismo fue la Atención Primaria de Cataluña (España). Los sujetos de estudio fueron personas de entre 35-75 años de edad, que cumplían los criterios de SM, sin ECV al inicio del seguimiento (2009). La población se estratificó según el índice MEDEA en rural, y dentro de áreas urbanas en 5 subcategorías (urbano1 - urbano5), según su nivel de deprivación. Se realizó estadística descriptiva, análisis de la varianza y curvas de supervivencia (Kaplan-Meier, método de Cox) para contrastar los diferentes grupos categóricos. Resultados: Se analizaron 401.743 sujetos con SM (17,2% de la población catalana); 20,1% residían en áreas rurales. Su edad media osciló entre 60,5 + 9,6 años en área urbana 1 (la más favorecida) y 59,6 + 10,4 años en área urbana 5 (la más precaria). A los 5 años de seguimiento, la incidencia global de ECV fue del 5,5%, siendo ligeramente menor en ámbito rural (5%) que en los urbanos (entre 5,5-5,8%). En cambio, la mortalidad fue superior en el ámbito rural (859 casos/100000 habitantes-año) - que en el resto de áreas (mínimo valor en urbano-3 (736 casos/100000 habitantes-año)). Conclusiones: El lugar de residencia constituye un marcador de riesgo, que se asocia a la incidencia de ECV pero sobre todo, a una mayor mortalidad por todas las causas, en pacientes con SM. Sin duda y dejando de lado los posibles factores de confusión, en las áreas socioeconómicamente más desfavorecidas, la mortalidad está aumentada
Background: In order to clarify the relation between deprivation and morbillity and mortality, in function of different residence places, we design this study. Main objective is to analyze the influence of place of residence on the incidence of cardiovascular events (CVD) and general mortality from any cause, in a cohort with metabolic syndrome. Methods: Prospective study to determine the incidence of CVD according to the place of residence (rural, urban) in individuals with different combinations of clinical features of Metabolic Syndrome (MS). Setting: Primary Care, Catalonia (Spain). Subjects: between 35-75 years of age fulfilling SM criteria, without CVD at the beginning of follow-up (2009). The population was stratified according to the MEDEA index in rural, and within urban areas in 5 subcategories (urban1 - urban5), according to their level of deprivation. We performed descriptive statistics, variance analysis and survival curves (Kaplan-Meier and Cox methods) in order to contrast data from different categories. Results: We analyzed 401,743 subjects with MS (17.2% of the Catalan population); 20.1% resided in rural areas. Their average age ranged between 60.5 + 9.6 years in urban area 1 (most favored) and 59.6 + 10.4 years in urban area 5 (the most precarious). After 5 years of follow-up, the global incidence of CVD was 5.5%, being slightly lower in rural areas (5%) than in urban areas (between 5.5% -5.8%). On the other hand, mortality was higher in the rural area (859 deaths/100000 inhabitants-year) - than in the rest of the areas (minimum value in urban-3 (736 deaths/100000 inhabitants-year)). Conclusions: The place of residence is a risk marker, which is associated with the incidence of CVD but above all, with higher mortality from all causes in patients with MS. Undoubtedly and leaving aside the possible confounding factors, in the socioeconomically most disadvantaged areas, mortality is increased
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Síndrome Metabólica/mortalidade , Doenças Cardiovasculares/mortalidade , Fatores de Risco , Causas de Morte/tendências , Fatores Socioeconômicos , Condições Sociais , Áreas de Pobreza , Estudos ProspectivosRESUMO
BACKGROUND: The aim of this study was to assess the association of key adiposity markers with lung function in smokers without respiratory disease in a Mediterranean population. METHODS: We performed a cross-sectional study with baseline data from a representative sample of the ESPITAP study in Spain. Participants were 738 smokers (52.3% men) without respiratory disease, aged 35 to 70, selected from 12 primary health care centres. We assessed weight, height, body mass index (BMI), waist circumference (WC) and waist-to-height ratio (WHtR). The pulmonary functional parameters were forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1) and FEV1/FVC ratio. RESULTS: In this cohort of smokers, 22.2% of individuals had central obesity. FVC% was inversely associated with all anthropometric measures (BMI, WC and WHtR) in the overall population and in men; in women, only BMI was associated with FVC%. FEV1% was inversely associated to BMI and WC in the overall population, and to all anthropometric measures in men. Furthermore, both BMI and obesity were positively associated with FEV1/FVC ratio overall and when stratified by sex; this suggests a restrictive pattern explained by the altered ventilator mechanics experienced by people with obesity. CONCLUSION: In a Mediterranean population of smokers without respiratory symptoms, abdominal obesity, evaluated not only by BMI and WC but also WHtR, is inversely associated with lung function. Fat distribution appears more strongly related to pulmonary function parameters in men than in women. In smokers with high values for WC, WHtR and BMI, assessment of lung function is recommended. TRIAL REGISTRATION: Current Controlled Trials NCT01194596 . Registered 2 September 2010.
Assuntos
Adiposidade , Pulmão/fisiopatologia , Obesidade Abdominal/epidemiologia , Fumar/epidemiologia , Adulto , Biomarcadores , Índice de Massa Corporal , Estudos Transversais , Feminino , Volume Expiratório Forçado , Humanos , Modelos Lineares , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Espanha , Espirometria , Capacidade VitalRESUMO
En este trabajo se describe qué son los esteroles vegetales, la estructura química de los mismos para entender su mecanismo de acción hipocolesterolemiante, así como sus indicaciones y sus contraindicaciones en la práctica clínica
This paper describes what are plant sterols, the chemical structure to understand their mechanism of cholesterol-lowering action, and indications and contraindications in clinical practice
Assuntos
Humanos , Fitosteróis/farmacocinética , Anticolesterolemiantes/farmacocinética , Doenças Cardiovasculares/prevenção & controle , Hipercolesterolemia/tratamento farmacológico , Fatores de Risco , Padrões de Prática MédicaRESUMO
BACKGROUND: Diet can help preserve lung function in smokers, in addition to avoidance of smoking. The study aimed to evaluate associations between dietary patterns and lung function in smokers without respiratory disease. METHODS: This cross-sectional study analysed baseline data from randomised representative smokers without respiratory disease (n = 207, aged 35-70 years), selected from 20 primary health-care centres. Participants completed a validated semi-quantitative food-frequency questionnaire. Dietary patterns were identified by Principal Component Analysis (PCA). Impaired lung function was defined as FVC <80% and/or FEV1 < 80% of predicted value and/or FEV1/FVC <0.7. Associations were determined by logistic regression. RESULTS: Three major dietary patterns were identified. In multivariate-adjusted model, impaired lung function was associated with the Alcohol-consumption pattern (OR 4.56, 95% CI 1.58-13.18), especially in women (OR 11.47, 95% CI 2.25-58.47), and with the Westernised pattern in women (OR 5.62, 95% CI 1.17-27.02), whereas it not was associated with the Mediterranean-like pattern (OR 0.71, 95% CI 0.28-1.79). CONCLUSION: In smokers without respiratory disease, the Alcohol-consumption pattern and the Westernised pattern are associated with impaired lung function, especially in women. The Mediterranean-like pattern appears to be associated with preserved lung function because no statistical association is observed with impaired lung function. In addition to smoking cessation, modifying dietary patterns has possible clinical application to preserve lung function.
Assuntos
Consumo de Bebidas Alcoólicas/efeitos adversos , Dieta Mediterrânea , Dieta Ocidental/efeitos adversos , Pulmão/fisiopatologia , Fumar/fisiopatologia , Adulto , Estudos Transversais , Exercício Físico , Feminino , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Estudos Multicêntricos como Assunto , Análise Multivariada , Ensaios Clínicos Controlados Aleatórios como Assunto , Transtornos Respiratórios , Testes de Função Respiratória , Fatores Sexuais , Classe Social , Espanha , Inquéritos e QuestionáriosRESUMO
This paper describes what are plant sterols, the chemical structure to understand their mechanism of cholesterol-lowering action, and indications and contraindications in clinical practice.
Assuntos
Anticolesterolemiantes/uso terapêutico , Fitosteróis/uso terapêutico , Anticolesterolemiantes/química , Anticolesterolemiantes/farmacologia , Colesterol/sangue , Humanos , Fitosteróis/química , Fitosteróis/farmacologiaRESUMO
BACKGROUND: Spirometry is the recommended method of evaluating pulmonary function when respiratory disease is suspected in smokers. Nonetheless, no evidence exists of the usefulness of information obtained from this test as a motivational strategy for smoking cessation. The primary objective of this study is to evaluate the effectiveness of a motivational intervention based on spirometry results in achieving long-term smoking cessation. METHODS/DESIGN: We propose a multicenter randomized clinical trial in the primary care setting. STUDY SUBJECTS: We will recruit active smokers of both sexes, aged 35-70 years, with a cumulated smoking habit exceeding 10 packs/year and who consult for any reason with their primary care physician in the 20 health centers in the province of Tarragona (Spain). Patients with a history of lung disease or who have undergone exploratory measures of pulmonary function in the preceding 12 months will be excluded. All patients who agree to participate will provide signed informed consent prior to their inclusion. A total of 1000 smokers will be consecutively randomized to a control or intervention group (1:1). INTERVENTION: Participants in both groups will receive brief (5-minute) health counseling, in accordance with usual clinical practice. In a consultation lasting about 15 minutes, participants in the intervention group will also receive detailed, personalized information about the results of a spirometry test and about their lung age compared with their chronological age. Both groups will be followed up for 12 months. Main variables and analysis: The main variable will be sustained smoking abstinence at 12 months after the intervention, as confirmed by CO breath testing and urine cotinine test. Results will be analyzed based on intention to treat, using the chi-square test and logistical regression if necessary to adjust for confounding variables. DISCUSSION: We expect the rate of prolonged smoking abstinence in the intervention group will be at least 5% higher than in the control group. If this strategy proves effective, it could easily be included in the health promotion activities offered in primary care settings. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02153047 . Registered on 28/05/2014.
Assuntos
Entrevista Motivacional/métodos , Atenção Primária à Saúde/métodos , Abandono do Hábito de Fumar/métodos , Fumar/terapia , Adulto , Idoso , Feminino , Promoção da Saúde , Humanos , Pulmão/fisiopatologia , Masculino , Pessoa de Meia-Idade , Fumar/fisiopatologia , EspirometriaRESUMO
BACKGROUND: There is evidence of an association between pulmonary function and various nutrients, although no association has been observed in our setting between the Mediterranean Diet (MD) eating pattern and improved lung function. The objective of this study is to evaluate the effect of an intervention designed to increase MD adherence on lung function in smokers with no previous respiratory disease. METHODS/DESIGN: Randomized, controlled, parallel clinical trial. SETTING: primary health care centers in Catalonia (Spain). PARTICIPANTS: Current smokers (cumulative > 10 pack-years) aged 35-70 years, with Internet access, who provide signed informed consent to participate. INTERVENTION: A nutritionist will conduct a 2-year multicomponent intervention to increase MD adherence, based on: 1) a personalized dietary-nutritional education intervention, 2) a Web 2.0 approach, the DIET Blog of nutritional information, and 3) group sessions to increase motivation to increase MD adherence and motivation to make changes in eating habits. Annually, an office visit and one group session will reinforce the nutritional intervention. The control group will follow their usual diet, with general nutritional counselling. In both groups, a 14-item questionnaire will evaluate individual MD dietary patterns and forced spirometry will assess lung function. ANALYSIS: Intention to treat. The unit of analysis will be the individual smoker. Primary outcome is lung function indicated by spirometry, FVC, FEV1 and FEV1/FVC %. Lung function parameters in both groups will be compared by adherence to the MD pattern. DISCUSSION: The DIET study could contribute data on a protective action of the MD pattern on lung function in smokers. If so, this population may benefit from a nutritional intervention, along with the fundamental recommendation to stop smoking. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02151669 . Registered 26 May 2014.
Assuntos
Dieta Mediterrânea , Pulmão/fisiologia , Fumar/fisiopatologia , Adulto , Idoso , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Testes de Função Respiratória , Espanha , Inquéritos e QuestionáriosRESUMO
BACKGROUND: Elevated ferritin levels have been associated with single cardiovascular risk factors but the relationship to the presence of metabolic syndrome is inconclusive.The aim of this systematic review and meta-analysis of published observational studies was to estimate the association between serum ferritin levels and metabolic syndrome in adults. METHODS: The Pubmed, SCOPUS and the Cochrane Library databases were searched for epidemiological studies that assessed the association between ferritin levels and metabolic syndrome and were published before September 2013. There were no language restrictions. Two investigators independently selected eligible studies. Measures of association were pooled by using an inverse-variance weighted random-effects model. The heterogeneity among studies was examined using the I2 index. Publication bias was evaluated using the funnel plot. RESULTS: Twelve cross-sectional, one case-control and two prospective studies met our inclusion criteria including data from a total of 56,053 participants. The pooled odds ratio (OR) for the metabolic syndrome comparing the highest and lowest category of ferritin levels was 1.73 (95% CI: 1.54, 1.95; I2 = 75,4%). Subgroup analyses indicate that pooled OR was 1.92 (95% CI: 1.61, 2.30; I2 = 78%) for studies adjusting for C-reactive protein (CRP), and 1.52 (95% CI:1. 36, 1.69; I2 = 41%) for studies that did not adjust for CRP (P = 0.044). This finding was remarkably robust in the sensitivity analysis. We did not find publication bias. CONCLUSIONS: The meta-analysis suggests that increased ferritin levels are independently and positively associated with the presence of the metabolic syndrome with an odds ratio higher than 1.73.
Assuntos
Ferritinas/sangue , Síndrome Metabólica/sangue , Adulto , Estudos de Casos e Controles , Estudos Transversais , Feminino , Humanos , Masculino , Razão de Chances , Estudos Prospectivos , Fatores de RiscoRESUMO
La importancia de la grasa en la dieta, y su papel en la prevención cardiovascular, es uno de los tópicos nutricionales mejor estudiados y, a pesar de ello, está en continua revisión. Ahora ya conocemos, en especial gracias a los estudios relacionados con la dieta mediterránea, que es más importante la calidad de la grasa, que la cantidad de su ingesta. En ese sentido, la grasa saturada y la grasa trans están implicadas en el riesgo aterogénico, por lo que se recomienda que para el diseño de una dieta sana dichos nutrientes se deben sustituir por hidratos de carbono complejos o por grasas insaturadas, manteniendo el consumo de grasa saturada en < 10% y el de trans en < 1% de la ingesta calórica. Estudios poblacionales recientes, en especial el estudio de Kuopio y los trabajos realizados con el modelo de dieta mediterránea, están afianzando cada vez más la importancia de las grasas monoinsaturadas y poliinsaturadas, como nutrientes claves para la prevención de las enfermedades crónicas de las sociedades modernas(AU)
Por otra parte, un tipo especial de ácidos grasos poliinsaturados, los de la serie omega 3 (n-3), están gradualmente convirtiéndose en nutrientes claves de una dieta sana, especialmente en niños. Por ello parece razonable, que cuatro sociedades, fuertemente implicadas en difundir los beneficios de la dieta como herramienta para prevenir las enfermedades cardiovasculares, desarrollen un consenso para difundir los nuevos conocimientos sobre la importancia de conseguir un aporte equilibrado y adecuado de grasa, en la dieta de las poblaciones industrializadas. Esto justifica este documento realizado por un grupo de expertos de la Sociedad Española de Arteriosclerosis, la Sociedad Española de Medicina Familiar y Comunitaria, la Asociación Española de Pediatría, la Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica y la Sociedad Española de Dietética y Ciencias de la Alimentación, en un esfuerzo porque resulte un trabajo multidisciplinar, orientado tanto a los adultos como a los niños, en distintos tramos de edad(AU)
Although dietary fat and its role in cardiovascular prevention has been one of the most extensively studied nutritional topics, it continues to be an ever-expanding research area. Particularly thanks to studies on Mediterranean diet, we now know that fat quality is more relevant than the amount of fat we eat in the diet. Thus, saturated and trans fats have been found to increase the risk of atherogenic disease. This is why it is recommended to substitute complex carbohydrates or unsaturated fat for unsaturated and trans fats with the aim of reducing saturated and trans fat intake to <10% and <1%, respectively, of the total calorie intake. Recent population studies, particularly that conducted in Kuopio, Finland, and those on Mediterranean diet, stress the important role of monounsaturated and polyunsaturated fats as key nutrients in preventing cardiovascular disease in modern societies. Furthermore, a special type of polyunsaturated fatty acids, i.e. those of the omega-3 (n-3) series, is increasingly becoming essential nutrients for a healthy diet, especially in the case of children. Therefore, there is a rationale for four the Scientific Societies that are strongly committed to disseminate the benefits of a healthy diet in preventing cardiovascular disease, and to prepare a joint statement with the purpose of spreading improved knowledge on the importance of changing to a healthy diet with a well-balanced fat intake for industrialized populations. Accordingly, a multidisciplinary panel of experts from the following institutions has developed the present joint statement targeted at both adults and children of different ages: Spanish Society of Arteriosclerosis, Spanish Society of Family and Community Medicine, Spanish Association of Paediatrics, Spanish Society of Gastroenterology, Hepatology and Paediatric Nutrition and Dietetics, and Spanish Society for Food Sciences(AU)
Assuntos
Humanos , Gorduras na Dieta/efeitos adversos , Doenças Cardiovasculares/epidemiologia , Fatores de Risco , Ácidos Graxos Monoinsaturados/administração & dosagem , Ácidos Linoleicos/administração & dosagem , MargarinaAssuntos
Doenças Cardiovasculares/prevenção & controle , Inibidores de Hidroximetilglutaril-CoA Redutases/uso terapêutico , Hipercolesterolemia/tratamento farmacológico , Doenças Cardiovasculares/etiologia , Ensaios Clínicos como Assunto , Humanos , Hipercolesterolemia/complicações , Medição de Risco , Fatores de RiscoRESUMO
No disponible